Condition: Drug-eluting Stent · Coronary Artery Disease · Sponsor: Genoss Co., Ltd.
The purpose of this observational study is to evaluate the long-term effectiveness and safety of the OSFIT drug-eluting stent designed to facilitate procedures in coronary artery lesions. Additionally, the study aims to verify the accuracy of stent placement in the lesion of interest using Optical Coherence Tomography (OCT) among subgroups of participants. The primary endpoint was defined as the composite of target lesion failure (TLF) at the 12-month mark, including cardiac death, target vessel myocardial infarction (MI), or target lesion revascularization.
This description comes directly from the study's public registry record.
seong-jae TaK, MD, PhD · 820312195712 · stjahk@gmail.com
Nayeong Lee, RN · 820312195111 · yellowfox240@gmail.com
Always discuss trial participation with your own doctor first.
| Ajou University Hospital | Suwon, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06066450